dr cecchini on etrumadenant-based combinations in previously treated mcrc
Published 2 weeks ago • 39 plays • Length 0:54Download video MP4
Download video MP3
Similar videos
-
1:06
dr. pant on the future of mcrc treatment
-
3:04
treatment goals in refractory mcrc
-
0:58
dr. kim reviews studies investigating regorafenib in mcrc
-
4:00
immunotherapy combinations in msi and mss mcrc
-
0:57
dr. cercek on the need for treatment options in kras mutated mcrc
-
12:20
colon cancer (crc) signs & symptoms (& why they occur)
-
4:33
my colorectal cancer symptoms
-
37:19
how to treat and prevent colon polyps using functional medicine
-
0:11
life of young colon cancer survivor
-
3:43
importance of tumor sidedness in mcrc
-
1:45
breakwater: encorafenib plus cetuximab in patients with braf v600e-mutant mcrc
-
0:06
signs and symptoms of colorectal cancer
-
1:12
dr. atreya on how the nccn guidelines have impacted treatment options in mcrc
-
7:32
treatment options in refractory mcrc
-
0:52
dr. bendell on a phase ii study of onartuzumab in combination with bevacizumab for mcrc
-
1:05
dr. morris on treatment advances made in braf-mutated mcrc
-
1:37
dr. overman on next steps with immunotherapy in mcrc
-
1:05
how will the paradigm trial change the mcrc treatment landscape?
-
1:58
dr. kasi on role of immunotherapy in mcrc
-
1:08
dr. weinberg on the role of cetuximab in metastatic crc
-
0:42
dr. fakih on anti-angiogenesis versus anti-egfr therapy in colon cancer